How aware are clinicians that MS should no longer be considered a White people only disease? What roles have race and ethnicity been shown to play in MS disease severity and disability progression? What do health care professionals need to know to provi

Wheres the newer MS research leading? How has our understanding of noninflammatory progressive MS changed? How might these findings affect what happens in the clinic? Join us as we discuss these and other questions with Dr. Michael Kornberg from the

Is it true that a significant number of patients being treated for MS may not actually have the disease? What are the red flags warnings that something about the patients condition does not meet the accepted MS diagnostic criteria that need to be inv

In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems. Providing relief from these common MS symptoms often requires clinicians to go beyond the prescription pad to recommend nonpharmacologic treatments. What works? What

As people with MS age, how does their response to their long-term DMT change? Is there a time when disease-modifying therapy can be safely discontinued? In which patients? At what age? What role do comorbidities play in making these decisions?  

COVID-19 vaccination. For many people with multiple sclerosis, its not a simple and straightforward process. The DMT theyre currently taking to control disease progression and moderate their symptoms particularly if its a beta cell- de

Shared decision-making what does it mean in multiple sclerosis? Can it really help providers more fully understand their patients concerns? Can it motivate patients to more readily and enthusiastically take ownership of their disease? And most imp

As the number of new MS therapies continues to grow, so does the uncertainty about which management approach  escalation or highly effective disease-modifying therapy is best for each patient. What are the patient-specific factors t

Acomprehensive MS center what is it? Which clinicians comprise a multidisciplinary MS care team?How does comprehensiveMScarework in practice?How does it benefit patients?Thatsthe focus of this non-CME-accreditedeMultipleSclerosis Revie

The differencesin MS disease activity between children and adults.